OncLive – Clinical Oncology News, Cancer Expert Insights
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Matthew T. Campbell, MD, MS, discusses CAR T-cell therapy and immunotherapy advances in renal cell carcinoma.
Ashwin Kishtagari, MD, discusses the treatment of patients with myelofibrosis following progression on ruxolitinib.
Nature Reviews Cancer – Author Correction: Developmental origins shape the paediatric cancer genome
Discuss efficacy and safety results from QuANTUM-First, which was a phase 3, randomized, double-blind, placebo-controlled trial exploring VANFLYTA in patients with newly diagnosed FLT3-ITD+ AML…
RAG-01 has received an FDA fast track designation and is being investigated for the treatment of non-muscle invasive bladder cancer.
Michael J. Hall, MD, MS, FASCO, must occasionally remind himself not everyone holds genetics research in the high esteem he does.He recalled a middle-aged African…
An abstract is unavailable.
Interim analysis in the phase III CheckMate 77T trial has shown that the addition of perioperative nivolumab to neoadjuvant chemotherapy improved event-free survival in patients…
Triple-negative breast cancer is an aggressive type of breast cancer that can be hard to treat and often comes back. Breast medical oncologist Clinton Yam,…